173 related articles for article (PubMed ID: 38130754)
1. Utility and Limitations of TALLYHO/JngJ as a Model for Type 2 Diabetes-Induced Bone Disease.
Emini L; Salbach-Hirsch J; Krug J; Jähn-Rickert K; Busse B; Rauner M; Hofbauer LC
JBMR Plus; 2023 Dec; 7(12):e10843. PubMed ID: 38130754
[TBL] [Abstract][Full Text] [Related]
2. Low bone toughness in the TallyHO model of juvenile type 2 diabetes does not worsen with age.
Creecy A; Uppuganti S; Unal M; Clay Bunn R; Voziyan P; Nyman JS
Bone; 2018 May; 110():204-214. PubMed ID: 29438824
[TBL] [Abstract][Full Text] [Related]
3. Early-onset type 2 diabetes impairs skeletal acquisition in the male TALLYHO/JngJ mouse.
Devlin MJ; Van Vliet M; Motyl K; Karim L; Brooks DJ; Louis L; Conlon C; Rosen CJ; Bouxsein ML
Endocrinology; 2014 Oct; 155(10):3806-16. PubMed ID: 25051433
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria-Targeted Small Peptide, SS31 Ameliorates Diabetes Induced Mitochondrial Dynamics in Male TallyHO/JngJ Mice.
Bhatti JS; Thamarai K; Kandimalla R; Manczak M; Yin X; Kumar S; Vijayan M; Reddy PH
Mol Neurobiol; 2021 Feb; 58(2):795-808. PubMed ID: 33025510
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of a mitochondria-targeted small peptide SS31 against hyperglycemia-induced mitochondrial abnormalities in the liver tissues of diabetic mice, Tallyho/JngJ mice.
Bhatti JS; Tamarai K; Kandimalla R; Manczak M; Yin X; Ramasubramanian B; Sawant N; Pradeepkiran JA; Vijayan M; Kumar S; Reddy PH
Mitochondrion; 2021 May; 58():49-58. PubMed ID: 33639273
[TBL] [Abstract][Full Text] [Related]
6. Canagliflozin, an SGLT2 inhibitor, corrects glycemic dysregulation in TallyHO model of T2D but only partially prevents bone deficits.
Thrailkill KM; Bunn RC; Uppuganti S; Ray P; Popescu I; Kalaitzoglou E; Fowlkes JL; Nyman JS
Bone; 2020 Dec; 141():115625. PubMed ID: 32890778
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice.
Kim JH; Stewart TP; Soltani-Bejnood M; Wang L; Fortuna JM; Mostafa OA; Moustaid-Moussa N; Shoieb AM; McEntee MF; Wang Y; Bechtel L; Naggert JK
J Endocrinol; 2006 Nov; 191(2):437-46. PubMed ID: 17088413
[TBL] [Abstract][Full Text] [Related]
8. Increased tissue modulus and hardness in the TallyHO mouse model of early onset type 2 diabetes mellitus.
Arora D; Taylor EA; King KB; Donnelly E
PLoS One; 2023; 18(7):e0287825. PubMed ID: 37418415
[TBL] [Abstract][Full Text] [Related]
9. Reduced Bone Mass and Increased Osteocyte Tartrate-Resistant Acid Phosphatase (TRAP) Activity, But Not Low Mineralized Matrix Around Osteocyte Lacunae, Are Restored After Recovery From Exogenous Hyperthyroidism in Male Mice.
Wölfel EM; Lademann F; Hemmatian H; Blouin S; Messmer P; Hofbauer LC; Busse B; Rauner M; Jähn-Rickert K; Tsourdi E
J Bone Miner Res; 2023 Jan; 38(1):131-143. PubMed ID: 36331133
[TBL] [Abstract][Full Text] [Related]
10. Systemic Parathyroid Hormone Enhances Fracture Healing in Multiple Murine Models of Type 2 Diabetes Mellitus.
Alder KD; White AH; Chung YH; Lee I; Back J; Kwon HK; Cahill SV; Hao Z; Li L; Chen F; Lee S; Riedel MD; Lee FY
JBMR Plus; 2020 May; 4(5):e10359. PubMed ID: 32382692
[TBL] [Abstract][Full Text] [Related]
11. Reduced aldehyde dehydrogenase activity and arginine vasopressin receptor 2 expression in the kidneys of male TALLYHO/JngJ mice of prediabetic age.
Nakamura N
Endocrine; 2011 Dec; 40(3):379-85. PubMed ID: 21879339
[TBL] [Abstract][Full Text] [Related]
12. Protective Effects of Chaya against Mitochondrial and Synaptic Toxicities in the Type 2 Diabetes Mouse Model TallyHO.
Ramasubramanian B; Griffith C; Hanson M; Bunquin LE; Reddy AP; Hegde V; Reddy PH
Cells; 2022 Feb; 11(4):. PubMed ID: 35203393
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of bone fragility by pulsed electromagnetic fields in type 2 diabetic KK-Ay mice involving Wnt/β-catenin signaling.
Shao X; Yang Y; Tan Z; Ding Y; Luo E; Jing D; Cai J
Am J Physiol Endocrinol Metab; 2021 May; 320(5):E951-E966. PubMed ID: 33719588
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycemia and cognitive impairments anticipate the onset of an overt type 2 diabetes-like phenotype in TALLYHO/JngJ mice.
Presta M; Zoratto F; Mulder D; Ottomana AM; Pisa E; Arias Vásquez A; Slattery DA; Glennon JC; Macrì S
Psychoneuroendocrinology; 2024 Jun; 167():107102. PubMed ID: 38896988
[TBL] [Abstract][Full Text] [Related]
15. When Cortical Bone Matrix Properties Are Indiscernible between Elderly Men with and without Type 2 Diabetes, Fracture Resistance Follows Suit.
Wölfel EM; Bartsch B; Koldehoff J; Fiedler IAK; Dragoun-Kolibova S; Schmidt FN; Krug J; Lin MC; Püschel K; Ondruschka B; Zimmermann EA; Jelitto H; Schneider G; Gludovatz B; Busse B
JBMR Plus; 2023 Dec; 7(12):e10839. PubMed ID: 38130774
[TBL] [Abstract][Full Text] [Related]
16. Light at night exacerbates metabolic dysfunction in a polygenic mouse model of type 2 diabetes mellitus.
Russart KLG; Chbeir SA; Nelson RJ; Magalang UJ
Life Sci; 2019 Aug; 231():116574. PubMed ID: 31207311
[TBL] [Abstract][Full Text] [Related]
17. Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus.
Pereira M; Gohin S; Lund N; Hvid A; Smitham PJ; Oddy MJ; Reichert I; Farlay D; Roux JP; Cleasby ME; Chenu C
Osteoporos Int; 2017 Jan; 28(1):309-320. PubMed ID: 27468901
[TBL] [Abstract][Full Text] [Related]
18. Skeletal Response to Insulin in the Naturally Occurring Type 1 Diabetes Mellitus Mouse Model.
Dixit M; Liu Z; Poudel SB; Yildirim G; Zhang YZ; Mehta S; Murik O; Altarescu G; Kobayashi Y; Shimizu E; Schaffler MB; Yakar S
JBMR Plus; 2021 May; 5(5):e10483. PubMed ID: 33977201
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of bone strength and metabolism in type 2 diabetic model Tsumura, Suzuki, Obese Diabetes mice.
Tanaka H; Yamashita T; Yoneda M; Takagi S; Miura T
Bone Rep; 2018 Dec; 9():74-83. PubMed ID: 30094297
[TBL] [Abstract][Full Text] [Related]
20. Bone defect regeneration and cortical bone parameters of type 2 diabetic rats are improved by insulin therapy.
Picke AK; Gordaliza Alaguero I; Campbell GM; Glüer CC; Salbach-Hirsch J; Rauner M; Hofbauer LC; Hofbauer C
Bone; 2016 Jan; 82():108-15. PubMed ID: 26055107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
